Cite
HARVARD Citation
Berges, R. et al. (n.d.). P11.31 EB1-dependent survival of glioblastoma tumor-bearing mice after treatment with the novel checkpoint activator BAL101553 is associated with inhibition of cancer stem-like cell-mediated tumor angiogenesis and astrocytic differentiation. Neuro-oncology. pp. iii49-iii50. [Online].